Ontology type: schema:ScholarlyArticle
2014-01
AUTHORSG. Simonetti, E. Trevisan, A. Silvani, P. Gaviani, A. Botturi, E. Lamperti, D. Beecher, L. Bertero, C. Bosa, A. Salmaggi
ABSTRACTAngiogenesis has recently become a major target for the development of new antineoplastic drugs. The most serious adverse events linked to angiogenesis inhibitors are venous or arterial thromboembolism and haemorrhage. Thus, there is need to define with more certainty the impact of these new drugs in terms of adverse effects in neurological patients. The aim of the study is to assess the risk of venous thromboembolism (VTE) and bleeding in patients with malignant gliomas treated with bevacizumab with or without concomitant anticoagulant therapy. A review of published literature was performed in Medline, from which 476 records were identified. A total of 27 full-text articles, including retrospective analyses, retrospective reviews, and open label trials, were assessed for eligibility. The investigated drugs included bevacizumab alone, bevacizumab plus chemotherapy with/without concomitant radiation therapy; only two articles dealt with bevacizumab in association with anticoagulant treatment. A total of 2,208 patients with malignant gliomas, were identified and included in the analysis. From data it appears that patients receiving bevacizumab had a major risk of developing VTE that increased when bevacizumab is associated with radio-chemotherapy (4.27 vs 7.46 %). Regarding bleeding, data showed that patients treated with anticoagulant had a significantly increased risk of severe central nervous system (CNS) bleeding compared to patients not receiving anticoagulant therapy (0.6 vs 8.2 %). The use of bevacizumab combined with chemo-radiotherapy seems to be associated with a higher risk for VTE compared to patients receiving antiangiogenic therapy alone. The associated use of anticoagulants and bevacizumab far increases the risk of developing CNS and non-CNS bleeding higher than grade 3, compared to patients receiving bevacizumab alone. More... »
PAGES83-89
http://scigraph.springernature.com/pub.10.1007/s10072-013-1583-6
DOIhttp://dx.doi.org/10.1007/s10072-013-1583-6
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1047201631
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/24281944
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Angiogenesis Inhibitors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antibodies, Monoclonal, Humanized",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Bevacizumab",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Brain Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Glioma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Venous Thromboembolism",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Istituto Neurologico Carlo Besta",
"id": "https://www.grid.ac/institutes/grid.417894.7",
"name": [
"Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
],
"type": "Organization"
},
"familyName": "Simonetti",
"givenName": "G.",
"id": "sg:person.01252270246.05",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252270246.05"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Azienda Ospedaliero Universitaria San Giovanni Battista",
"id": "https://www.grid.ac/institutes/grid.413005.3",
"name": [
"Division of Neuro-oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Turin, Italy"
],
"type": "Organization"
},
"familyName": "Trevisan",
"givenName": "E.",
"id": "sg:person.01210506657.44",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210506657.44"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Istituto Neurologico Carlo Besta",
"id": "https://www.grid.ac/institutes/grid.417894.7",
"name": [
"Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
],
"type": "Organization"
},
"familyName": "Silvani",
"givenName": "A.",
"id": "sg:person.01337217237.92",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337217237.92"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Istituto Neurologico Carlo Besta",
"id": "https://www.grid.ac/institutes/grid.417894.7",
"name": [
"Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
],
"type": "Organization"
},
"familyName": "Gaviani",
"givenName": "P.",
"id": "sg:person.01265330306.32",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265330306.32"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Istituto Neurologico Carlo Besta",
"id": "https://www.grid.ac/institutes/grid.417894.7",
"name": [
"Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
],
"type": "Organization"
},
"familyName": "Botturi",
"givenName": "A.",
"id": "sg:person.01266121043.19",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266121043.19"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Istituto Neurologico Carlo Besta",
"id": "https://www.grid.ac/institutes/grid.417894.7",
"name": [
"Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
],
"type": "Organization"
},
"familyName": "Lamperti",
"givenName": "E.",
"id": "sg:person.01204520207.23",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204520207.23"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Istituto Neurologico Carlo Besta",
"id": "https://www.grid.ac/institutes/grid.417894.7",
"name": [
"Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous, System Review Group, Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
],
"type": "Organization"
},
"familyName": "Beecher",
"givenName": "D.",
"id": "sg:person.0576721171.03",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576721171.03"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Azienda Ospedaliero Universitaria San Giovanni Battista",
"id": "https://www.grid.ac/institutes/grid.413005.3",
"name": [
"Division of Neuro-oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Turin, Italy"
],
"type": "Organization"
},
"familyName": "Bertero",
"givenName": "L.",
"id": "sg:person.01141770554.98",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141770554.98"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Azienda Ospedaliero Universitaria San Giovanni Battista",
"id": "https://www.grid.ac/institutes/grid.413005.3",
"name": [
"Division of Neuro-oncology, Department of Neuroscience, University and San Giovanni Battista Hospital, Turin, Italy"
],
"type": "Organization"
},
"familyName": "Bosa",
"givenName": "C.",
"id": "sg:person.01256217154.30",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256217154.30"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Istituto Neurologico Carlo Besta",
"id": "https://www.grid.ac/institutes/grid.417894.7",
"name": [
"Department of Neurooncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"
],
"type": "Organization"
},
"familyName": "Salmaggi",
"givenName": "A.",
"id": "sg:person.0614374604.44",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614374604.44"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1016/j.ccr.2006.11.021",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000989893"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11060-005-9097-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001104504",
"https://doi.org/10.1007/s11060-005-9097-6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11060-005-9097-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001104504",
"https://doi.org/10.1007/s11060-005-9097-6"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1634/theoncologist.2010-0105",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001559376"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s1470-2045(09)70025-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1002463620"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1001/archinte.166.4.458",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1003211102"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/cncr.23401",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1003264880"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/neuonc/nop073",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1003769500"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/neuonc/nop073",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1003769500"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-06-2309",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004441322"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11060-008-9599-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004532009",
"https://doi.org/10.1007/s11060-008-9599-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf00177615",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1005617755",
"https://doi.org/10.1007/bf00177615"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3109/0284186x.2011.572913",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006425289"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1159/000314980",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008619638"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/cncr.25462",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009168434"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/00005792-199909000-00001",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010057240"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/00005792-199909000-00001",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010057240"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1586/14737140.4.2.303",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1010214744"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.jocn.2009.12.009",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012060047"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/neuonc/nor223",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1013332503"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11060-008-9718-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1014358667",
"https://doi.org/10.1007/s11060-008-9718-y"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2010.30.2729",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017963788"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ijrobp.2007.11.068",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1018476686"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdp591",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019574105"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1158/1078-0432.ccr-11-0120",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019815454"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/1097-0142(20000801)89:3<640::aid-cncr20>3.0.co;2-e",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021056940"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ijrobp.2010.08.058",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024642299"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1227/01.neu.0000370918.51053.bc",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1025819952"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/cncr.26188",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028514124"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1080/02841860802537924",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033303184"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.critrevonc.2006.01.004",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1034298471"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s12325-011-0007-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1037365997",
"https://doi.org/10.1007/s12325-011-0007-3"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ijrobp.2010.09.002",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1039009019"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2008.19.8721",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042965400"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/cncr.24179",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045011263"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1001/jama.2008.656",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048505634"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2009.22.0616",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048915750"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11060-011-0579-4",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049920194",
"https://doi.org/10.1007/s11060-011-0579-4"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2009.22.3271",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050418707"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s11060-011-0642-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1051876399",
"https://doi.org/10.1007/s11060-011-0642-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf01403001",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052399274",
"https://doi.org/10.1007/bf01403001"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf01403001",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052399274",
"https://doi.org/10.1007/bf01403001"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.disamonth.2005.03.010",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052672038"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2003.99.046",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064204075"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064350042"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064350042"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064350042"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1212/wnl.0b013e3181a413be",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064354319"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1212/wnl.0b013e3181a413be",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064354319"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1212/wnl.0b013e3181a413be",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064354319"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1215/15228517-2008-009",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064414329"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3171/jns.2007.106.4.601",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1071102269"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3171/jns.2007.106.4.601",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1071102269"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3171/jns.2007.106.4.601",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1071102269"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/neuonc/nop063",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1078148309"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/neuonc/noq099",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1078202685"
],
"type": "CreativeWork"
}
],
"datePublished": "2014-01",
"datePublishedReg": "2014-01-01",
"description": "Angiogenesis has recently become a major target for the development of new antineoplastic drugs. The most serious adverse events linked to angiogenesis inhibitors are venous or arterial thromboembolism and haemorrhage. Thus, there is need to define with more certainty the impact of these new drugs in terms of adverse effects in neurological patients. The aim of the study is to assess the risk of venous thromboembolism (VTE) and bleeding in patients with malignant gliomas treated with bevacizumab with or without concomitant anticoagulant therapy. A review of published literature was performed in Medline, from which 476 records were identified. A total of 27 full-text articles, including retrospective analyses, retrospective reviews, and open label trials, were assessed for eligibility. The investigated drugs included bevacizumab alone, bevacizumab plus chemotherapy with/without concomitant radiation therapy; only two articles dealt with bevacizumab in association with anticoagulant treatment. A total of 2,208 patients with malignant gliomas, were identified and included in the analysis. From data it appears that patients receiving bevacizumab had a major risk of developing VTE that increased when bevacizumab is associated with radio-chemotherapy (4.27 vs 7.46 %). Regarding bleeding, data showed that patients treated with anticoagulant had a significantly increased risk of severe central nervous system (CNS) bleeding compared to patients not receiving anticoagulant therapy (0.6 vs 8.2 %). The use of bevacizumab combined with chemo-radiotherapy seems to be associated with a higher risk for VTE compared to patients receiving antiangiogenic therapy alone. The associated use of anticoagulants and bevacizumab far increases the risk of developing CNS and non-CNS bleeding higher than grade 3, compared to patients receiving bevacizumab alone.",
"genre": "research_article",
"id": "sg:pub.10.1007/s10072-013-1583-6",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1294956",
"issn": [
"1590-1874",
"1126-5442"
],
"name": "Neurological Sciences",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "35"
}
],
"name": "Safety of bevacizumab in patients with malignant gliomas: a systematic review",
"pagination": "83-89",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"e0da6ccbfc730b4f6cb9990c66edadfd609d112647ecff0a100feb712b0229e6"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"24281944"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"100959175"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s10072-013-1583-6"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1047201631"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s10072-013-1583-6",
"https://app.dimensions.ai/details/publication/pub.1047201631"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-10T23:29",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8693_00000534.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007%2Fs10072-013-1583-6"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10072-013-1583-6'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10072-013-1583-6'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10072-013-1583-6'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10072-013-1583-6'
This table displays all metadata directly associated to this object as RDF triples.
314 TRIPLES
21 PREDICATES
83 URIs
29 LITERALS
17 BLANK NODES